{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,5,29]],"date-time":"2022-05-29T10:41:28Z","timestamp":1653820888153},"reference-count":49,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"1","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["JCO Clinical Cancer Informatics"],"published-print":{"date-parts":[[2017,11]]},"abstract":"<jats:sec><jats:title>Purpose<\/jats:title><jats:p> Despite the plethora of randomized controlled trial (RCT) data, most cancer treatment recommendations are formulated by experts. Alternatively, network meta-analysis (NMA) is one method of analyzing multiple indirect treatment comparisons. However, NMA does not account for mixed end points or temporality. Previously, we described a prototype information theoretical approach for the construction of ranked chemotherapy treatment regimen networks. Here, we propose modifications to overcome an apparent straw man effect, where the most studied regimens were the most negatively valued. <\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p> RCTs from two scenarios\u2014upfront treatment of chronic myelogenous leukemia and relapsed\/refractory multiple myeloma\u2014were assembled into ranked networks using an automated algorithm based on effect sizes, statistical significance, surrogacy of end points, and time since RCT publication. Vertex and edge color, transparency, and size were used to visually analyze the network. This analysis led to the additional incorporation of value propagation. <\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p> A total of 18 regimens with 42 connections (chronic myelogenous leukemia) and 28 regimens with 25 connections (relapsed\/refractory multiple myeloma) were analyzed. An initial negative correlation between vertex value and size was ameliorated after value propagation, although not eliminated. Updated rankings were in close agreement with published guidelines and NMAs. <\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p> Straw man effects can distort the comparative efficacy of newer regimens at the expense of older regimens, which are often cheaper or less toxic. Using an automated method, we ameliorated this effect and produced rankings consistent with common practice and published guidelines in two distinct cancer settings. These findings are likely to be generalizable and suggest a new means of ranking efficacy in cancer trials. <\/jats:p><\/jats:sec>","DOI":"10.1200\/cci.17.00079","type":"journal-article","created":{"date-parts":[[2017,11,15]],"date-time":"2017-11-15T21:04:53Z","timestamp":1510779893000},"page":"1-9","update-policy":"http:\/\/dx.doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":1,"title":["Overcoming the Straw Man Effect in Oncology: Visualization and Ranking of Chemotherapy Regimens Using an Information Theoretic Approach"],"prefix":"10.1200","author":[{"given":"Jeremy L.","family":"Warner","sequence":"first","affiliation":[{"name":"Jeremy L. Warner, Vanderbilt University, Nashville, TN; Peter C. Yang, Massachusetts General Hospital; and Gil Alterovitz, Harvard Medical School and Harvard-Massachusetts Institute of Technology Division of Health Science, Boston; and Massachusetts Institute of Technology, Cambridge, MA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter C.","family":"Yang","sequence":"additional","affiliation":[{"name":"Jeremy L. Warner, Vanderbilt University, Nashville, TN; Peter C. Yang, Massachusetts General Hospital; and Gil Alterovitz, Harvard Medical School and Harvard-Massachusetts Institute of Technology Division of Health Science, Boston; and Massachusetts Institute of Technology, Cambridge, MA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gil","family":"Alterovitz","sequence":"additional","affiliation":[{"name":"Jeremy L. Warner, Vanderbilt University, Nashville, TN; Peter C. Yang, Massachusetts General Hospital; and Gil Alterovitz, Harvard Medical School and Harvard-Massachusetts Institute of Technology Division of Health Science, Boston; and Massachusetts Institute of Technology, Cambridge, MA."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"233","reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2008.04.010"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d1199"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70388-7"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60108-1"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61444-5"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2016003905"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.71.1663"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1109\/MCG.2008.2"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.artmed.2010.02.001"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1000353"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-11-126"},{"key":"B12","first-page":"62","volume":"192","author":"Warner J","year":"2013","journal-title":"Stud Health Technol Inform"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.2014.001511"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.53.8009"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2010.134"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.8.2787-2792.2004"},{"key":"B18","doi-asserted-by":"crossref","unstructured":"Cha M: Propagation phenomena in large social networks. Presented at the 23rd International Conference on World Wide Web, Seoul, Korea, April 7-11, 2014.","DOI":"10.1145\/2567948.2579367"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1002315"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa022457"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1037\/0278-7393.26.3.566"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3406\/comm.1970.1221"},{"key":"B26","doi-asserted-by":"crossref","unstructured":"Moreland K: Diverging color maps for scientific visualization. Presented at the 5th International Symposium on Advances in Visual Computing: Part II, Las Vegas, Nevada, November 30-December 2, 2009.","DOI":"10.1007\/978-3-642-10520-3_9"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1109\/MCG.2007.323435"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1098\/rspb.1980.0020"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1126\/science.149.3688.1115"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2015.05.006"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-125-7-199610010-00011"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.38.7571"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2015.2829"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22528"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.2009.02240.x"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-08-358135"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.66.2866"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2015.11.007"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.59.3228"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1613493"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-010-0116-1"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-11-682518"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-02-700872"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2016-0368"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-01-725705"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-9-79"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1001\/2012.jama.11228"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-11-159"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.61.6706"},{"key":"B54","doi-asserted-by":"crossref","unstructured":"Schnipper LE, Davidson NE, Wollins DS, et al: Updating the American Society of Clinical Oncology Value Framework: Revisions and reflections in response to comments received. J Clin Oncol 34:2925-2934, 2016.","DOI":"10.1200\/JCO.2016.68.2518"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1186\/1745-6215-8-16"},{"key":"B58","unstructured":"Dietterich TG: Ensemble methods in machine learning, in Kittler J, Roli, F (eds.): Multiple Classifier Systems. First International Workshop, MCS 2000 Cagliari, Italy, June 21-23, 2000 Proceedings. Berlin, Germany, Springer 2000: 1-15."},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1001\/jama.291.20.2457"}],"container-title":["JCO Clinical Cancer Informatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/CCI.17.00079","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,29]],"date-time":"2022-05-29T10:14:15Z","timestamp":1653819255000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/CCI.17.00079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["10.1200\/CCI.17.00079"],"URL":"https:\/\/doi.org\/10.1200\/cci.17.00079","relation":{},"ISSN":["2473-4276"],"issn-type":[{"value":"2473-4276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"2017-11-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}